ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

MORGAN STANLEY's Holding History (CIK: 0000895421)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 411,823 Value ($000) $6,342 Avg Close $19.92 Range $15.14 - $24.64

Q3 2025

Shares 258,384 Value ($000) $5,289 Avg Close $20.16 Range $17.43 - $24.38

Q2 2025

Shares 254,848 Value ($000) $5,112 Avg Close $18.93 Range $13.30 - $24.11

Q1 2025

Shares 81,315 Value ($000) $1,600 Avg Close $21.52 Range $18.67 - $25.37

Q4 2024

Shares 110,606 Value ($000) $2,489 Avg Close $25.92 Range $21.43 - $30.03

Q3 2024

Shares 135,407 Value ($000) $3,458 Avg Close $23.16 Range $20.63 - $27.67

Q2 2024

Shares 68,300 Value ($000) $1,596 Avg Close $21.05 Range $15.96 - $26.00

Q1 2024

Shares 63,097 Value ($000) $1,110 Avg Close $15.34 Range $10.90 - $19.50

Q4 2023

Shares 79,521 Value ($000) $1,101 Avg Close $12.23 Range $9.80 - $15.41

Q3 2023

Shares 33,970 Value ($000) $464 Avg Close $16.84 Range $12.38 - $20.77

Q2 2023

Shares 33,321 Value ($000) $680 Avg Close $20.21 Range $17.15 - $23.98

Q1 2023

Shares 17,418 Value ($000) $381 Avg Close $20.34 Range $14.56 - $25.34

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	411,823	$6,342	$19.92	$15.14 - $24.64
Q3 2025	258,384	$5,289	$20.16	$17.43 - $24.38
Q2 2025	254,848	$5,112	$18.93	$13.30 - $24.11
Q1 2025	81,315	$1,600	$21.52	$18.67 - $25.37
Q4 2024	110,606	$2,489	$25.92	$21.43 - $30.03
Q3 2024	135,407	$3,458	$23.16	$20.63 - $27.67
Q2 2024	68,300	$1,596	$21.05	$15.96 - $26.00
Q1 2024	63,097	$1,110	$15.34	$10.90 - $19.50
Q4 2023	79,521	$1,101	$12.23	$9.80 - $15.41
Q3 2023	33,970	$464	$16.84	$12.38 - $20.77
Q2 2023	33,321	$680	$20.21	$17.15 - $23.98
Q1 2023	17,418	$381	$20.34	$14.56 - $25.34